Author Correction: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)

Zhicheng Yao; Shida Yang; Hongyou Zhao; Huike Yang; Xin Jiang

doi:10.1038/s41417-019-0082-1

Author Correction: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)

Zhicheng Yao
, Shida Yang
, Hongyou Zhao
, Huike Yang
, Xin Jiang^*

^*此作品的通讯作者

The People’s Hospital of Liaoning Province
Louisiana State University Health Sciences Center
Harbin Medical University

科研成果: 期刊稿件 › 评论/辩论

摘要

All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People’s Hospital of Liaoning Province as indicated in the original version of the Article. The PDF and HTML versions of the Article have been modified accordingly.

源语言	英语
页（从-至）	257
页数	1
期刊	Cancer Gene Therapy
卷	26
期	7-8
DOI	https://doi.org/10.1038/s41417-019-0082-1
出版状态	已出版 - 1 7月 2019
已对外发布	是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

可持续发展目标 3 良好健康与福祉

访问文件

10.1038/s41417-019-0082-1

其它文件与链接

链接到 Scopus 的出版物

引用此

@article{267d9821fe6441fa9120a2dbe9ce9e19,

title = "Author Correction: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)",

abstract = "All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People{\textquoteright}s Hospital of Liaoning Province as indicated in the original version of the Article. The PDF and HTML versions of the Article have been modified accordingly.",

author = "Zhicheng Yao and Shida Yang and Hongyou Zhao and Huike Yang and Xin Jiang",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature America, Inc.",

year = "2019",

month = jul,

day = "1",

doi = "10.1038/s41417-019-0082-1",

language = "English",

volume = "26",

pages = "257",

journal = "Cancer Gene Therapy",

issn = "0929-1903",

publisher = "Springer Nature",

number = "7-8",

}

TY - JOUR

T1 - Author Correction

T2 - BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)

AU - Yao, Zhicheng

AU - Yang, Shida

AU - Zhao, Hongyou

AU - Yang, Huike

AU - Jiang, Xin

PY - 2019/7/1

Y1 - 2019/7/1

N2 - All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People’s Hospital of Liaoning Province as indicated in the original version of the Article. The PDF and HTML versions of the Article have been modified accordingly.

AB - All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People’s Hospital of Liaoning Province as indicated in the original version of the Article. The PDF and HTML versions of the Article have been modified accordingly.

UR - https://www.scopus.com/pages/publications/85061236332

U2 - 10.1038/s41417-019-0082-1

DO - 10.1038/s41417-019-0082-1

M3 - Comment/debate

C2 - 30723270

AN - SCOPUS:85061236332

SN - 0929-1903

VL - 26

SP - 257

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

IS - 7-8

ER -

Author Correction: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)

摘要

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此